The impact of the COVID-19 pandemic on hepatocellular carcinoma diagnosis and treatment in Japan - a multicenter collaborative observational study.
Kazuhiro MuraiHayato HikitaTakahiro KodamaMasaki KaiboriYuki NishimuraTomohide TatsumiTomomi YamadaTatsuya KantoSatoshi MochidaTetsuo TakeharaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2023)
The number of HCC-related general medical practices decreased during the first SOE. However, the COVID-19 pandemic did not lead to HCC progression by diagnostic delays or cause HCC treatment delays in Japan. This article is protected by copyright. All rights reserved.